AXIM Biotechnologies, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-2.5M | $-2.5M | $40.5K | $1.1M |
| FY2022 | $-2.0M | $-2.1M | $8.7K | $1.1M |
| FY2023 | $-1.0M | $-1.0M | $0 | $197.7K |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-2.5M | $-2.5M | $40.5K | $1.1M |
| FY2022 | $-2.0M | $-2.1M | $8.7K | $1.1M |
| FY2023 | $-1.0M | $-1.0M | $0 | $197.7K |